The changes to the regulations surrounding cannabis-based medicines come as the NSW government invests $21 million to further evidence-based research into their safe and effective use.
NSW Premier Mike Baird has endorsed the move, as the new medicines can now be considered by doctors for patients who have exhausted standard treatment options.
"People who are seriously ill should be able to access these medicines if they are the most appropriate next step in their treatment," Mr Baird said.
“This change increases the options available for doctors as it means a broader range of cannabis-based medicines can be prescribed - while we continue our evidence-based research looking further into the role medicinal cannabis can play.”
Applications from prescribing doctors will be assessed by the Commonwealth Therapeutic Goods Administration and by a committee of medical experts on behalf of NSW Health. Minister for Medical Research Pru Goward stressed the importance of evidence-based research into the safe and effective use of cannabis-based medicines, saying that NSW was regulating these medicines in the same way as any other emerging medicine.
For further information about the NSW Government’s medicinal cannabis initiatives visit NSW Health or call 1800 217 257.